{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:12Z","timestamp":1791414132633,"version":"4.3.3"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ijantimicag.2009.10.023","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T09:29:38Z","timestamp":1262165378000},"page":"282-287","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada"],"prefix":"10.1016","volume":"35","author":[{"given":"Michael A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.10.023_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1469-0691.2009.02740.x","article-title":"Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens","volume":"15","author":"Cornaglia","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1128\/AAC.00231-08","article-title":"First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States","volume":"52","author":"Mendes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MCC.0b013e32827851d7","article-title":"Old antibiotics for infections in critically ill patients","volume":"13","author":"Falagas","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib4","first-page":"765","article-title":"Fusidic acid: new opportunities with an old antibiotic","volume":"122","author":"Anderson","year":"1980","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1086\/499365","article-title":"Dumb and dumber\u2014the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus","volume":"42","author":"Howden","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/adc.2003.019695","article-title":"Fusidic acid resistance in Staphylococcus aureus","volume":"89","author":"Dobie","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib7","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib8","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib9","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.42.7.1762","article-title":"Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)","volume":"42","author":"Pfaller","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/jac\/dkn071","article-title":"High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis","volume":"61","author":"McLaws","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jac\/dkn456","article-title":"Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France","volume":"63","author":"Laurent","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/JCM.01984-06","article-title":"Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus","volume":"45","author":"O\u2019Neill","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2007.02.015","article-title":"Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use","volume":"30","author":"Sule","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/dkf217","article-title":"A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway","volume":"50","author":"Tveten","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.10.023_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2310\/7750.2006.00064","article-title":"Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data","volume":"10","author":"Rennie","year":"2006","journal-title":"J Cutan Med Surg"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790900510X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790900510X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T21:27:58Z","timestamp":1558733278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790900510X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S092485790900510X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.10.023","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}